16/05/2024  15:18:58 Chg. -27.0000 Volume Bid15:19:04 Demandez à15:19:04 Capitalisation boursière Dividende Y. Rapport P/E
1,785.5000GBX -1.49% 1.35 Mio.
Chiffrre d'affaires(GBP): 23.56 Mio.
1,785.5000Bid taille: 289 1,786.0000Ask la taille: 2,163 71.99 Mrd.GBP - -

Description de l'entreprise

GSK is a british pharmaceutical and healthcare company. GSK manufactures drugs and vaccines for major disease areas such as asthma, cancer, infections, diabetes, digestive and mental health conditions. Many medicines were historically discovered or developed at GSK and its predecessor companies and are now sold as generics.
 

Conseil d'administration & Conseil de surveillance

PDG
Emma Walmsley
Conseil d'administration
Julie Brown, Diana Conrad, James Ford, Luke Miels, Sally Jackson, Tony Wood, Shobie Ramakrishnan, David Redfern, Regis Simard, Phil Thomson, Deborah Waterhouse
Conseil de surveillance
Jonathan Symonds, Emma Walmsley, Iain Mackay, Elizabeth (Liz) McKee Anderson, Charles Bancroft, Dr. Hal Barron, Dr. Anne Beal, Dr. Harry (Hal) C Dietz, Dr. Jesse Goodman, Urs Rohner, Dr. Vishal Sikka, Wendy Becker, Dr. Jeannie Lee
 

Données de l'entreprise

Nom: GlaxoSmithKline PLC
Adresse: 980 Great West Road,UK-Brentford, Middlesex TW8 9GS
Téléphone: +44-20-8047-5000
Fax: -
Courriel: -
Internet: www.gsk.com
Industrie: Healthcare
Secteur: Pharmaceutical Industry
Sous-secteur: Pharmaceuticals
Fin de l'exercice financier: 31/12
Flotte libre: 41.74%
IPO date: -

Relations avec les investisseurs

Nom: Nick Stone
Téléphone IR: +44 7717 618834
IR-Fax: -
E-mail IR: GSK.Investor-Relations@gsk.com

Calendrier de l'entreprise

CW 20 | 16/05/2024 Ex-Dividend
CW 20 | 17/05/2024 Record Date
CW 28 | 11/07/2024 Dividend Payment
CW 31 | 31/07/2024 Interim Report 2nd Quarter/6 Months
CW 44 | 30/10/2024 Interim Report 3rd Quarter/9 Months
 

Principaux actionnaires

Autres
 
89.27%
BlackRock, Inc
 
5.69%
Dodge & Cox
 
5.04%